Surgical resection of lung adenocarcinoma without EGFR mutation after neoadjuvant gefitinib treatment.
Shen
Hong
H
Department of Oncology, 2nd Hospital of Zhejiang University College of Medicine, Hangzhou, China.
Zhong
Xian
X
Ge
Xiao-Qin
XQ
Huang
Jian-Jin
JJ
Yuan
Ying
Y
D000230:Adenocarcinoma / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000601:surgery; D000368:Aged; D001707:Biopsy, Needle; D017024:Chemotherapy, Adjuvant; D005260:Female; D000077156:Gefitinib; D018773:Genes, erbB-1 / Q000235:genetics; D006801:Humans; D007223:Infant; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000601:surgery; D009154:Mutation / Q000235:genetics; D020360:Neoadjuvant Therapy; D011013:Pneumonectomy; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed
D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000077156:Gefitinib